P251 (Hyoscyamine sulfate extended release 0.375 mg)

Pill imprint P251 has been identified as Hyoscyamine sulfate extended release 0.375 mg.

Hyoscyamine is used in the treatment of irritable bowel syndrome; anesthesia; crohn's disease; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine 0.375 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hyoscyamine sulfate extended release

Imprint:

P251

Strength:

0.375 mg

Color:

White

Size:

13.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Anticholinergics/antispasmodics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Paddock Laboratories, Inc.

National Drug Code (NDC):

00574-0251

Inactive Ingredients:

lactose anhydrous
hypromellose 2208 (15000 mPa.s)
silicon dioxide
magnesium stearate

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.